Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maribel Díaz-Ricart

Showing results (41-50 of 57) with videos related to

Pageof 6
Sort By:
Thrombosis and Haemostasis|January 14, 2025
Endothelial Damage in JAK2V617F Myeloproliferative Neoplasms with Splanchnic Vein ThrombosisBlanca De Moner, Julia Martinez-Sanchez, Marta Garrote, et al.
Blood Reviews|June 9, 2024
Endothelial injury and dysfunction with emerging immunotherapies in multiple myeloma, the impact of COVID-19, and endothelial protection with a focus on the evolving role of defibrotideClifton C Mo, Edward Richardson, Eleonora Calabretta, et al.
Transplantation and Cellular Therapy|April 20, 2026
Incidence, Risk Factors and Outcomes of Sinusoidal Obstruction Syndrome in Patients undergoing Allogeneic Hematopoietic Cell Transplantation with PTCy-based ProphylaxisLaura Creus-Vilalta, María Suárez-Lledó, Julia Martínez-Sánchez, et al.
Heart & Lung : the Journal of Critical Care|June 18, 2026
Impaired hemostasis in mechanical circulatory support systems: Monitoring with T-TAS® 01, in vitro correction with VWF concentrates, and impact of membrane oxygenatorsSilvia Escribano-Serrat, Ana Belén Moreno-Castaño, Marc Pino, et al.
Biomolecules|July 29, 2025
Defibrotide for Protecting Against and Managing Endothelial Injury in Hematologic Malignancies and COVID-19Edward Richardson, Clifton C Mo, Eleonora Calabretta, et al.
Transplantation and Cellular Therapy|October 20, 2025
Modifying Post-Transplant Cyclophosphamide Platform to Improve Safety in HLA-Matched Allogeneic HCT: A Reduced Dose Plus Adjunctive StrategiesFilipe R Pinto, María Queralt Salas, María Suárez-Lledó, et al.
Shock (Augusta, Ga.)|June 26, 2021
Distinctive Biomarker Features in the Endotheliopathy of COVID-19 and Septic SyndromesSara Fernández, Ana B Moreno-Castaño, Marta Palomo, et al.
Bone Marrow Transplantation|May 1, 2018
Innovative strategies minimize engraftment syndrome in multiple myeloma patients with novel induction therapy following autologous hematopoietic stem cell transplantationGonzalo Gutiérrez-García, Montserrat Rovira, Laura Magnano, et al.
Bone Marrow Transplantation|March 24, 2024
EASIX and cardiac adverse events after allogeneic hematopoietic cell transplantationCarles Tolosa-Ridao, Enric Cascos, Luis Gerardo Rodríguez-Lobato, et al.
Transplantation and Cellular Therapy|November 24, 2023
Easix Score Correlates With Endothelial Dysfunction Biomarkers and Predicts Risk of Acute Graft-Versus-Host Disease After Allogeneic TransplantationAlexandra Pedraza, María Queralt Salas, Luis Gerardo Rodríguez-Lobato, et al.
Pageof 6

Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
Thrombosis and Haemostasis|January 14, 2025
Endothelial Damage in JAK2V617F Myeloproliferative Neoplasms with Splanchnic Vein ThrombosisBlanca De Moner, Julia Martinez-Sanchez, Marta Garrote, et al.
Blood Reviews|June 9, 2024
Endothelial injury and dysfunction with emerging immunotherapies in multiple myeloma, the impact of COVID-19, and endothelial protection with a focus on the evolving role of defibrotideClifton C Mo, Edward Richardson, Eleonora Calabretta, et al.
Transplantation and Cellular Therapy|April 20, 2026
Incidence, Risk Factors and Outcomes of Sinusoidal Obstruction Syndrome in Patients undergoing Allogeneic Hematopoietic Cell Transplantation with PTCy-based ProphylaxisLaura Creus-Vilalta, María Suárez-Lledó, Julia Martínez-Sánchez, et al.
Heart & Lung : the Journal of Critical Care|June 18, 2026
Impaired hemostasis in mechanical circulatory support systems: Monitoring with T-TAS® 01, in vitro correction with VWF concentrates, and impact of membrane oxygenatorsSilvia Escribano-Serrat, Ana Belén Moreno-Castaño, Marc Pino, et al.
Biomolecules|July 29, 2025
Defibrotide for Protecting Against and Managing Endothelial Injury in Hematologic Malignancies and COVID-19Edward Richardson, Clifton C Mo, Eleonora Calabretta, et al.
Transplantation and Cellular Therapy|October 20, 2025
Modifying Post-Transplant Cyclophosphamide Platform to Improve Safety in HLA-Matched Allogeneic HCT: A Reduced Dose Plus Adjunctive StrategiesFilipe R Pinto, María Queralt Salas, María Suárez-Lledó, et al.
Shock (Augusta, Ga.)|June 26, 2021
Distinctive Biomarker Features in the Endotheliopathy of COVID-19 and Septic SyndromesSara Fernández, Ana B Moreno-Castaño, Marta Palomo, et al.
Bone Marrow Transplantation|May 1, 2018
Innovative strategies minimize engraftment syndrome in multiple myeloma patients with novel induction therapy following autologous hematopoietic stem cell transplantationGonzalo Gutiérrez-García, Montserrat Rovira, Laura Magnano, et al.
Bone Marrow Transplantation|March 24, 2024
EASIX and cardiac adverse events after allogeneic hematopoietic cell transplantationCarles Tolosa-Ridao, Enric Cascos, Luis Gerardo Rodríguez-Lobato, et al.
Transplantation and Cellular Therapy|November 24, 2023
Easix Score Correlates With Endothelial Dysfunction Biomarkers and Predicts Risk of Acute Graft-Versus-Host Disease After Allogeneic TransplantationAlexandra Pedraza, María Queralt Salas, Luis Gerardo Rodríguez-Lobato, et al.
Pageof 6